Login

Galera Therapeutics, Inc. SEC Filings

Filed On Filing
14 Aug 2026 SCHEDULE 13G/A
07 Aug 2026 EFFECT
05 Aug 2026 Form 4: Sorensen Mel, Director

Returned 975 shares to the issuer · Disposed of 30,000 Stock Option (Right to Buy) (Disposition to Issuer)

05 Aug 2026 Form 4: Lokay Kevin G, Director

Disposed of 240 Stock Option (Right to Buy) (Disposition to Issuer)

05 Aug 2026 Form 4: Chang Nancy T, Director

Received 661,309 shares by conversion · Returned 47,434 shares to the issuer · Disposed of 480 Stock Option (Right to Buy) (Disposition to Issuer)

05 Aug 2026 Form 4: Alleva Lawrence M, Director

Returned 51 shares to the issuer · Disposed of 240 Stock Option (Right to Buy) (Disposition to Issuer)

05 Aug 2026 Form 4: Sussman Joel F., Chief Accounting Officer

Disposed of 10,000 Stock Option (Right to Buy) (Disposition to Issuer)

05 Aug 2026 Form 4: Friedman Michael R., Director

Received 2,989,399 shares by conversion · Returned 41,631 shares to the issuer · Disposed of 480 Stock Option (Right to Buy) (Disposition to Issuer)

04 Aug 2026 15-12G
04 Aug 2026 POS AM
04 Aug 2026 S-8 POS
04 Aug 2026 S-8 POS
04 Aug 2026 8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +5 more
31 Jul 2026 8-K: Unregistered Sales of Equity Securities; Regulation FD Disclosure
13 Jul 2026 DEFA14C
13 Jul 2026 8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year
07 Jul 2026 DEFA14C
07 Jul 2026 8-K: Other Events
02 Jul 2026 DEFM14C
11 Jun 2026 SCHEDULE 13D

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support